This non-CME symposium is not part of the ATC official educational program and the sessions and content are not endorsed by ATC.
Sunday, June 2, 2019
12:45 PM – 1:00 PM ET
Join us for a spirited clinical case-based discussion amongst world-renowned experts. Ask your challenging questions about antibody-mediated rejection (AMR) in renal transplant patients and learn about emerging therapies for improved patient outcomes.
After engaging in this activity, transplant clinicians will be able to:
Clinicians who manage antibody-mediated rejection (AMR) in patients who undergo solid organ transplant (SOT).
This educational activity was independently developed by RMEI Medical Education, LLC, in collaboration with Advancing Knowledge in Healthcare (AKH) Inc. All faculty and planner conflicts of interest were identiﬁed and resolved and AKH has reviewed the content and determined it to be fair, balanced, and without commercial bias.
STATEMENT OF SUPPORT
This activity is supported by an independent educational grant from CSL Behring.
There is no fee for this educational activity.
Please contact Nicole Fortune at email@example.com if you have any questions.
Additional educational activities offered by RMEI Medical Education, LLC can be found
at www.RMEI.com or by calling toll-free (866) 770-RMEI.